83 related articles for article (PubMed ID: 1796925)
1. Localization of 14C-nizatidine in the gastric wall of rats.
Sano H; Mera Y; Arai K; Suzuki M; Sato H; Matsuda K
Arzneimittelforschung; 1991 Sep; 41(9):958-61. PubMed ID: 1796925
[TBL] [Abstract][Full Text] [Related]
2. Effects of successive doses of nizatidine, cimetidine and ranitidine on serum gastrin level and gastric acid secretion.
Yamaji Y; Omata T; Abe T; Yoshida A; Ueki S; Aita H; Morita H; Chaki K; Segawa Y; Kurimoto T
Arzneimittelforschung; 1991 Sep; 41(9):954-7. PubMed ID: 1796924
[TBL] [Abstract][Full Text] [Related]
3. Effects of the new anti-ulcer drug nizatidine on prostaglandins in the rat gastric mucosa.
Segawa Y; Takei M; Omata T; Tsuzuike N; Yamaji Y; Kurimoto T; Ozeki M; Tagashira E
Arzneimittelforschung; 1991 Sep; 41(9):950-3. PubMed ID: 1796923
[TBL] [Abstract][Full Text] [Related]
4. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs.
Lin TM; Evans DC; Warrick MW; Pioch RP
J Pharmacol Exp Ther; 1986 Nov; 239(2):406-10. PubMed ID: 2877081
[TBL] [Abstract][Full Text] [Related]
5. General pharmacology of nizatidine in animals.
Bemis K; Bendele A; Clemens J; Deldar A; Gidda J; Hamelink J; Holland D; Lamishaw B; McGrath J; Shannon H
Arzneimittelforschung; 1989 Feb; 39(2):240-50. PubMed ID: 2567169
[TBL] [Abstract][Full Text] [Related]
6. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
7. Absorption, distribution and excretion of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate in rats, dogs and monkeys.
Ando T; Momota K; Sugiyama M
Arzneimittelforschung; 1986 Aug; 36(8):1221-8. PubMed ID: 3778559
[TBL] [Abstract][Full Text] [Related]
8. Effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl)phenyl] propionic acid hydrochloride on gastric mucosa directly from the lumen.
Hoshina K; Tanabe H; Yamazaki N; Yamamoto M; Ohba T; Takeshita T; Naruchi T
Arzneimittelforschung; 1987 Nov; 37(11):1289-95. PubMed ID: 3440038
[TBL] [Abstract][Full Text] [Related]
9. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[TBL] [Abstract][Full Text] [Related]
10. Disposition and metabolism of [14C]-haloperidol in rats.
Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
[TBL] [Abstract][Full Text] [Related]
11. Sucralfate: pharmacokinetics, metabolism and selective binding to experimental gastric and duodenal ulcers in animals.
Steiner K; Bühring KU; Faro HP; Garbe A; Nowak H
Arzneimittelforschung; 1982; 32(5):512-8. PubMed ID: 6896647
[TBL] [Abstract][Full Text] [Related]
12. Actions of nizatidine on the rat uterus, dog stomach and experimentally induced gastric lesions.
Lin TM; Evans DC; Warrick MW; Ruffolo RR
J Pharmacol Exp Ther; 1986 Nov; 239(2):400-5. PubMed ID: 3095539
[TBL] [Abstract][Full Text] [Related]
13. Metabolic fate of the new Ca++-channel blocking agent (+)-(2S,3S)-3-acetoxy-8-chloro-(2-(dimethylamino)ethyl)-2,3-dihydro- 2-(4-methoxyphenyl)-2,5-benzothiazepin-4-(5H)-one maleate. Distribution, excretion and protein binding in rats and dogs.
Nakamura S; Ohashi M; Suzuki T; Sugawara Y; Usuki S; Takaiti O
Arzneimittelforschung; 1989 Sep; 39(9):1100-8. PubMed ID: 2590259
[TBL] [Abstract][Full Text] [Related]
14. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
15. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K; Kato S; Yamamoto H; Okabe S
Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
[TBL] [Abstract][Full Text] [Related]
16. Radiographic Localization Study of a Novel Potassium-Competitive Acid Blocker, Vonoprazan, in the Rat Gastric Mucosa.
Matsukawa J; Kogame A; Tagawa Y; Inatomi N
Dig Dis Sci; 2016 Jul; 61(7):1888-94. PubMed ID: 26961787
[TBL] [Abstract][Full Text] [Related]
17. Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats.
Ueki S; Seiki M; Yoneta T; Aita H; Chaki K; Hori Y; Morita H; Tagashira E; Itoh Z
J Pharmacol Exp Ther; 1993 Jan; 264(1):152-7. PubMed ID: 8093722
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
Ito K; Kinoshita K; Tomizawa A; Inaba F; Morikawa-Inomata Y; Makino M; Tabata K; Shibakawa N
J Pharmacol Exp Ther; 2007 Oct; 323(1):308-17. PubMed ID: 17630360
[TBL] [Abstract][Full Text] [Related]
19. Protection by galanin against gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.
Iishi H; Tatsuta M; Baba M; Uehara H; Nakaizumi A
Cancer Res; 1994 Jun; 54(12):3167-70. PubMed ID: 7515766
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
